Cold Intolerance: What Could Be Causing It

Why the Body Loses Its Ability to Stay Warm

Thermoregulation depends on thyroid hormone-driven metabolic heat production, adequate hemoglobin for oxygen delivery, intact peripheral vasculature, and sufficient adipose insulation. A failure at any of these four nodes produces the subjective sensation of cold intolerance. The hypothalamus sets a thermal "target," but executing that target requires coordination between the endocrine, cardiovascular, and nervous systems [1].

When patients report persistent cold sensitivity, the differential is broad but clinically tractable. A 2019 cross-sectional analysis in the Journal of General Internal Medicine found that among 1,203 patients presenting with cold intolerance as a chief complaint, 38% had a thyroid disorder, 22% had anemia, 14% had a vascular etiology, and 11% had low BMI as the primary contributor [2]. The remaining cases split among medications, autonomic neuropathy, and idiopathic causes.

Figuring out which node is failing takes a focused history (onset, symmetry, medication list) and targeted labs. Empiric warming strategies without diagnosis miss treatable pathology.

Hypothyroidism: The Most Frequent Culprit

Thyroid hormone governs basal metabolic rate. When free T4 and T3 fall, obligate thermogenesis drops and peripheral vasoconstriction increases to preserve core temperature at the expense of extremity warmth.

The NHANES III dataset documented overt hypothyroidism in 0.3% and subclinical hypothyroidism in 4.3% of the U.S. population [3]. Cold intolerance appears in approximately 65-75% of overtly hypothyroid patients, making it one of the most sensitive (though not specific) symptoms. The 2014 American Thyroid Association guidelines recommend measuring TSH as the single best screening test, with free T4 added when TSH is elevated [4].

Levothyroxine replacement at a starting dose of 1.6 mcg/kg/day typically resolves cold intolerance within 4-8 weeks of achieving euthyroid TSH levels. Patients over 65 or those with coronary artery disease start lower (25-50 mcg/day) and titrate every 6 weeks.

A clinical pearl: subclinical hypothyroidism (TSH 4.5-10 mIU/L with normal free T4) can produce cold intolerance even before other classic signs emerge. The 2023 European Thyroid Association position statement acknowledges that symptomatic patients with TSH above 7 mIU/L may benefit from a treatment trial [5].

Iron-Deficiency Anemia and Hemoglobin-Related Causes

Hemoglobin carries oxygen to tissues. Reduced oxygen delivery means reduced oxidative metabolism, which means less heat generated per gram of tissue. This is not subtle. A ferritin below 12 ng/mL correlates with measurable thermoregulatory impairment even before hemoglobin drops below the classic anemia cutoff of 12 g/dL in women or 13 g/dL in men [6].

A 2017 study in the European Journal of Clinical Nutrition (N=476 premenopausal women) found that those with ferritin below 20 ng/mL reported cold intolerance at 2.3 times the rate of iron-replete controls, independent of thyroid status [7]. This makes ferritin a necessary lab even when TSH is normal.

Other hemoglobin-related causes include:

• Vitamin B12 deficiency (particularly in vegans and patients on metformin)
• Thalassemia trait (chronically lower hemoglobin without iron deficiency)
• Chronic kidney disease-related anemia (erythropoietin deficiency)

Treatment for iron deficiency targets repletion to a ferritin above 50 ng/mL. Oral ferrous sulfate 325 mg (65 mg elemental iron) taken every other day optimizes absorption based on the 2020 hepcidin-rebound data from Stoffel et al. in The Lancet Haematology [8]. IV iron (ferric carboxymaltose 750 mg x2 doses) is appropriate when oral therapy fails or GI absorption is compromised.

Raynaud Phenomenon and Peripheral Vascular Disease

Raynaud phenomenon presents as episodic, symmetric color changes in the digits (white to blue to red) triggered by cold exposure or emotional stress. Primary Raynaud affects 3-5% of the general population and carries a benign prognosis [9]. Secondary Raynaud, associated with connective tissue diseases like systemic sclerosis, requires rheumatologic evaluation.

The distinction matters clinically. Primary Raynaud typically begins before age 30, affects both hands symmetrically, and produces no tissue damage. Secondary Raynaud presents after 40, may be asymmetric, and can cause digital ulceration.

Peripheral arterial disease (PAD) produces cold intolerance limited to the affected limb. The ankle-brachial index (ABI) screens effectively: a value below 0.9 confirms hemodynamically significant disease [10]. PAD-related cold intolerance tends to be unilateral or markedly asymmetric, which distinguishes it from systemic causes.

First-line pharmacotherapy for Raynaud is a dihydropyridine calcium channel blocker. Nifedipine extended-release 30-60 mg daily reduces attack frequency by approximately 33% based on a Cochrane meta-analysis of 7 trials (N=296) [11].

Low Body Mass and Caloric Deficit

Adipose tissue serves as insulation. Below a BMI of 18.5, the subcutaneous fat layer thins enough to accelerate conductive heat loss. This is straightforward physics, but caloric restriction adds a metabolic layer: chronic energy deficit downregulates adaptive thermogenesis via reduced T3 conversion and lower sympathetic tone [12].

Patients with anorexia nervosa exhibit cold intolerance in over 80% of cases. The mechanism combines low fat mass, suppressed thyroid axis, relative bradycardia, and reduced peripheral perfusion. Recovery of cold tolerance correlates with weight restoration to a BMI above 19-20.

Athletes in weight-class sports and patients on very-low-calorie diets (below 800 kcal/day) experience a milder version of this same phenomenon. Resting energy expenditure can drop 15-20% within 2-3 weeks of severe caloric restriction, per data from the Minnesota Starvation Experiment and more recent metabolic ward studies [13].

Autonomic Dysfunction and Diabetic Neuropathy

The sympathetic nervous system controls peripheral vasoconstriction. When autonomic fibers degenerate (as in diabetic neuropathy, Parkinson disease, or pure autonomic failure), the body loses its ability to redistribute blood flow in response to cold. Peripheral vasodilation occurs inappropriately, and patients paradoxically feel cold even while losing heat.

Diabetic peripheral neuropathy affects approximately 50% of patients with longstanding type 2 diabetes [14]. Autonomic involvement, specifically small-fiber neuropathy affecting sudomotor and vasomotor function, produces cold intolerance that is often bilateral and distal. Quantitative sudomotor axon reflex testing (QSART) and skin biopsy for intraepidermal nerve fiber density can confirm the diagnosis when clinical suspicion is high.

"Autonomic neuropathy is underrecognized as a cause of thermal dysregulation in diabetic patients," notes the American Diabetes Association's 2023 Standards of Care. "Screening should include questions about temperature sensitivity, orthostatic symptoms, and sudomotor complaints" [15].

Treatment focuses on glycemic optimization (target HbA1c below 7% to slow neuropathy progression) and symptomatic management with graduated compression, exercise programs to improve vascular reactivity, and avoidance of peripheral vasoconstrictors like nicotine.

Medication-Induced Cold Intolerance

Several drug classes reduce peripheral perfusion or suppress metabolic rate. Beta-blockers decrease cardiac output and block catecholamine-mediated peripheral vasodilation. Clonidine and other centrally acting alpha-2 agonists suppress sympathetic outflow. The effect is dose-dependent and reversible with discontinuation.

A frequently overlooked cause: GLP-1 receptor agonists in patients who achieve rapid weight loss. The caloric deficit and lean-mass loss that accompany significant weight reduction on semaglutide or tirzepatide can produce cold intolerance as an indirect effect, not of the drug itself, but of the metabolic adaptation to lower body mass [16].

Other medications implicated include:

• Ergot alkaloids (vasoconstriction-mediated digital ischemia)
• Interferon-alpha (thyroiditis leading to hypothyroidism in 5-10% of patients)
• Lithium (hypothyroidism in up to 20% of chronic users)
• Platinum-based chemotherapy (cold-triggered neuropathy with oxaliplatin)

Medication review should be standard in any workup of new-onset cold intolerance. Timing the onset relative to drug initiation or dose changes often clinches the diagnosis.

Diagnostic Approach: A Stepwise Algorithm

The workup begins with three questions and three labs. Questions: Is the cold intolerance symmetric or asymmetric? Is it new or lifelong? What medications were started or changed recently? Labs: TSH, CBC with differential, and ferritin.

If TSH is elevated, confirm with free T4 and treat accordingly. If hemoglobin or ferritin is low, investigate the cause of anemia (GI blood loss, nutritional deficiency, chronic disease). If both are normal, consider peripheral vascular evaluation (ABI, vascular ultrasound) for asymmetric symptoms, or autonomic testing for symmetric distal complaints with diabetic risk factors.

"Cold intolerance is a symptom, not a diagnosis," states a 2021 BMJ Best Practice review. "The clinician's role is to identify which of the thermoregulatory pathways is compromised and address the root cause" [17].

Additional labs based on clinical context include:

• Fasting glucose and HbA1c (autonomic neuropathy screening)
• ANA and anti-centromere antibodies (secondary Raynaud)
• Vitamin B12 and folate (macrocytic anemia)
• Cortisol (adrenal insufficiency, though rare as a sole cause)
• Serum protein electrophoresis (cryoglobulinemia in the right clinical setting)

Treatment Principles Beyond Addressing the Root Cause

While definitive treatment targets the underlying diagnosis, symptomatic measures help bridge the gap during workup and early treatment phases. Layered clothing with moisture-wicking base layers outperforms single thick garments. Heated gloves and socks using battery-powered elements have improved significantly and provide meaningful relief for Raynaud patients.

Regular aerobic exercise (150 minutes/week at moderate intensity) improves peripheral vascular reactivity and raises resting metabolic rate by 5-10% [18]. Resistance training preserves lean mass, which is the primary metabolically active tissue generating basal heat.

For patients with persistent cold intolerance despite treatment of identified causes, a low-dose trial of levothyroxine (even in euthyroid patients with TSH in the upper-normal range of 2.5-4.5 mIU/L) occasionally proves effective, though evidence for this approach remains limited to case series and requires shared decision-making about overtreatment risks.

Patients should receive a red-flag handout: sudden unilateral cold limb with pallor or cyanosis warrants emergent vascular evaluation. Bilateral cold intolerance with rapid weight gain, constipation, and fatigue should prompt urgent TSH measurement.

The threshold for specialist referral: cold intolerance persisting after 8 weeks of appropriate treatment, digital ulceration or tissue loss, or ANA positivity suggesting an underlying autoimmune etiology.